Search - tctmd.com

Displaying 301 - 320 of 4092

Sort: Relevancy | Date

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

Podcast TCTMD Talking Points

The HEART-FID Trial

November 20, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

Caitlin E. Cox

November 12, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Daily News

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Yael L. Maxwell

November 08, 2024

News Daily News

FDA Approves Varipulse Pulsed-Field Ablation System for AF

Michael O'Riordan

November 07, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

Podcast TCTMD Talking Points

The FIRE Study

November 06, 2024

Podcast Heart Valve Matters

Ethics of AI Detection of Subclinical Disease with Michael Mack

November 01, 2024

Podcast Heart Valve Matters

Economics of AI Detection of Subclinical Disease with Michael Mack

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Advertisement

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

The HEART-FID Trial

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Coronary CTA Reimbursement for US Hospitals to Double in 2025

FDA Approves Varipulse Pulsed-Field Ablation System for AF

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

The FIRE Study

Ethics of AI Detection of Subclinical Disease with Michael Mack

Economics of AI Detection of Subclinical Disease with Michael Mack

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content